Results 11 to 20 of about 6,740 (215)

Clinical Significance of Rotational Thromboelastometry (ROTEM) for Detection of Early Coagulopathy in Trauma Patients: A Retrospective Study [PDF]

open access: yesDiagnostics
Background: We aimed to evaluate the clinical significance of abnormal rotational thromboelastometry (ROTEM) findings in trauma patients and investigate the relationships between FIBTEM-maximum clot firmness (MCF), fibrinogen concentration and patient ...
Mohammad Asim   +15 more
doaj   +2 more sources

Transient hypofibrinogenemia due to allopurinol

open access: yesDrug Design, Development and Therapy, 2014
ZhiQiang Yin,1,* JiaLi Xu,2,* YongQiang Li,3,* JiPing Xia,1 Dan Luo1 1Department of Dermatology, 2Department of Oncology, 3Department of Rehabilitation Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's ...
Yin ZQ, Xu JL, Li YQ, Xia JP, Luo D
doaj   +5 more sources

Hemophagocytic Macrophages in the Peripheral Blood of a Critically Ill Patient With COVID-19 and RSV Infection. [PDF]

open access: yesAm J Hematol
American Journal of Hematology, Volume 101, Issue 5, Page 1070-1071, May 2026.
Zala A   +5 more
europepmc   +2 more sources

Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa

open access: yesThrombosis Journal, 2021
Background In patients with infectious diseases, disseminated intravascular coagulation (DIC) is often diagnosed without the fibrinogen value. The relationship between hypofibrinogenemia and outcomes of DIC in infectious diseases has thus remained ...
Kazuo Kawasugi   +11 more
doaj   +1 more source

Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis

open access: yesScientific Reports, 2023
Systemic juvenile idiopathic arthritis (SJIA) is a chronic inflammatory disease of childhood with elevated serum IL-6 levels. As an inhibitor of IL-6R, tocilizumab (TCZ) has been approved to treat SJIA patients.
Tingyan He, Jiayun Ling, Jun Yang
doaj   +1 more source

Clinical Characteristics of Hospitalized Neonates With Hypofibrinogenemia: A Retrospective Cohort Study

open access: yesFrontiers in Pediatrics, 2020
Background: Neonatal hypofibrinogenemia is often asymptomatic but can manifest as hemorrhage.Objective: This study was conducted to characterize clinical characteristics of neonates with hypofibrinogenemia and identify factors associated with hemorrhage ...
Weijun Zhou   +5 more
doaj   +1 more source

Congenital Hypofibrinogenemia in a Neonate with a Novel Mutation in the FGB Gene

open access: yesPediatric Reports, 2021
Detection of severe hypofibrinogenemia (
Jun Shinozuka   +6 more
doaj   +1 more source

Preeclampsia complicated with hypofibrinogenemia: 2 case reports and review of the literature

open access: yesBMC Pregnancy and Childbirth, 2023
Background Preeclampsia complicated with hypofibrinogenemia is a rare disorder. We report two cases of severe preeclampsia complicated with hypofibrinogenemia followed by postpartum haemorrhage (PPH).
Shiguang Li   +3 more
doaj   +1 more source

Gastrointestinal bleeding after endoscopic mucosal resection in a case of Peutz–Jeghers syndrome with hypofibrinogenemia: A case report

open access: yesFrontiers in Pediatrics, 2022
BackgroudPeutz–Jegers syndrome (PJS) is an autosomal dominant hereditary disorder characterized by hamartomatous polyposis of the entire gastrointestinal tract.
Toshihiko Kakiuchi   +5 more
doaj   +1 more source

SEVERE HYPOFIBRINOGENEMIA IN A PATIENT WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB: CASE-BASED REVIEW

open access: yesAnti-Aging Eastern Europe, 2023
The Giant cell arteritis (GCA) is the most common form of systemic vasculitis in elderly patients. The treatment includes high doses of steroids and interleukin (IL)-6 inhibitor tocilizumab, especially in refractory or relapsing disease or in cases where
Željka Kardum   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy